In a decision that was probably made easy by the Supreme Court’s recent Prometheus decision, a D.C. district court has invalidated, as patent ineligible under 35 U.S.C. § 101, patent claims that recite using a computer to recommend a therapeutic treatment regimen. SmartGene, Inc. v. Advanced Biological Laboratories, SA, No. 08-00642 (D. D.C. March 30, […]